Association between antihyperlipidemic agents and the risk of chronic periodontitis in patients with hyperlipidemia: A population‐based retrospective cohort study in Taiwan
Journal of Periodontology · 2024
DOI: 10.1002/jper.23-0166 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Periodontology, 2024. Verfasst von An-Yi Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Hyperlipidemias, Chronic Periodontitis, Hypolipidemic Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Taipei Medical University Hospital, Ministry of Science and Technology of Taiwan, Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
Background
The lipid‐lowering and anti‐inflammatory effects of statins and fibrates may ameliorate periodontitis. Patients with hyperlipidemia tend to have a worse periodontal status. This study assessed the association between the use of statins/fibrates and the incidence of chronic periodontitis in patients with hyperlipidemia in Taiwan.
Methods
This retrospective cohort study enrolled patients newly diagnosed with hyperlipidemia between 2001 and 2012 from the 2000 Longitudinal Generation Tracking Database and followed them for 5 years. The study population was divided into four groups: statin monotherapy, fibrate monotherapy, combination therapy (both statins and fibrates), and control (neither statins nor fibrates). Each patient in the treatment group was matched at a ratio of 1:1 with a control. Chronic periodontitis risk was compared in the three study arms by using a Cox proportional hazard model.
Results
Chronic periodontitis risk was reduced by 25.7% in the combination therapy group compared with the control group (adjusted hazard ratio [aHR], 0.743; 95% confidence interval (CI), 0.678–0.815). Low dose (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
- Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, USA.
- Department of Pharmacy, Taipei Medical University Hospital, Taipei, Taiwan.
Förderung
- Taipei Medical University Hospital
- Ministry of Science and Technology of Taiwan
- Ministry of Science and Technology, Taiwan
Zitieren
APA
Wang, A. Y., Lin, G. L., Keller, J. J., & Wang, L. H. (2024). Association between antihyperlipidemic agents and the risk of chronic periodontitis in patients with hyperlipidemia: A population‐based retrospective cohort study in Taiwan. Journal of Periodontology. https://doi.org/10.1002/jper.23-0166
Vancouver
Wang AY, Lin GL, Keller JJ, Wang LH. Association between antihyperlipidemic agents and the risk of chronic periodontitis in patients with hyperlipidemia: A population‐based retrospective cohort study in Taiwan. Journal of Periodontology. 2024. doi:10.1002/jper.23-0166
BibTeX
@article{Wang2024,
author = {Wang, An-Yi and Lin, Guan-Ling and Keller, Joseph Jordan and Wang, Li-Hsuan},
title = {Association between antihyperlipidemic agents and the risk of chronic periodontitis in patients with hyperlipidemia: A population‐based retrospective cohort study in Taiwan},
journal = {Journal of Periodontology},
year = {2024},
doi = {10.1002/jper.23-0166}
}
EUVIMED